Clinical trial Recruiting at 3 sites Phase 4 Interventional Ages 18 and up

Comparing CT-guided Lung Biopsy vs Shape-Sensing Robotic Bronchoscopy for Small Nodules

Official title: A Randomized Controlled Trial Evaluating Lung Nodules - COMparing Percutaneous CT-Guided Biopsy And Shape-Sensing Robotic-Assisted Bronchoscopy (ENCOMPASS)

Run by Intuitive Surgical · NCT07761351 · Data updated 2026-11-12

This trial tests whether shape-sensing robotic-assisted bronchoscopy with cone-beam CT can diagnose small lung nodules as well as the standard CT-guided lung biopsy, with a focus on safety.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment550 (estimated)
SponsorIntuitive Surgical
Industry-sponsored
Locations3 sites (Heidelberg and 2 other locations)
StatusRecruiting
StartedAugust 28, 2026
Main results expectedApril 30, 2028
Study endsApril 30, 2029
Registry record updatedSeptember 25, 2026
Trial IDNCT07761351 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a target pulmonary nodule ≤2 cm requiring diagnostic biopsy and who can provide informed consent.

Probably not a fit

Patients for whom the assigned biopsy method is unsuitable or who do not derive diagnostic benefit from biopsy may not experience improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ENCOMPASS trial is a multicenter, randomized study of adults with diagnostic nodules 2 cm or smaller to compare two biopsy approaches. Participants are randomly assigned to shape-sensing robotic-assisted bronchoscopy with cone-beam CT or to CT-guided percutaneous biopsy. The study aims to show non-inferior diagnostic efficacy and superior safety for the robotic approach, with peri-procedural pneumothorax as a key safety endpoint. Procedures follow standard clinical practice, and patients are followed up to 12 months with health status and quality-of-life assessments. If a patient’s assigned procedure is deemed unsuitable by the clinical team, they receive the best available standard care instead.

Why it matters

Potential benefit: If successful, patients with small pulmonary nodules could benefit from a biopsy method that provides similar diagnostic results with improved safety.

How similar studies have gone: Prior research has explored both CT-guided and robotic-assisted bronchoscopy approaches, with ongoing evaluation of safety and diagnostic yield in similar settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient is aged 18 years or older at time of consent.
2. Diagnostic nodule biopsy(s) indicated per multidisciplinary team (or equivalent).
3. Target pulmonary nodule ≤2 cm in largest diameter.
4. Patient is willing and able to give written informed consent for clinical study participation.

Exclusion Criteria:

1. Patient has previously undergone a biopsy procedure of the target nodule by any approach.
2. Patient was previously randomized in this study but did not undergo biopsy.
3. Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results.
4. Patient is pregnant or breastfeeding as determined by standard site practices.
5. Patient lacks the capacity to provide informed consent for themselves, or is a vulnerable patient whose ability to protect their own interests or to consent freely may be diminished, including but not limited to, patients who may be unduly influenced through dependency on the sponsor, the hospital, or the study doctor.
6. Patient is not willing to comply with study participation requirements.

Where it's running

  • Thoraxklinik Heidelberg
    Heidelberg, Germany
    Recruiting
  • Basel University Hospital
    Basel, Canton of Basel-City, Switzerland
    Recruiting
  • University College London Hospitals NHS Foundation
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.